"American Idol" Jamal Roberts accepted a key to the city in Alabama, but is rejecting an honor in Mississippi.

Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial ...

While Oscar Health has been reeling from Trump's "Beautiful" bill, the underlying low-cost offering could help lift OSCR stock.